R1 RCM Inc. found using ticker (RCM) now have 11 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 35 and 22 and has a mean target at 30.73. With the stocks previous close at 18.55 this now indicates there is a potential upside of 65.7%. The 50 day moving average now sits at 22.82 and the 200 day moving average is 23.4. The market capitalisation for the company is $7,749m. You can visit the company’s website by visiting: https://www.r1rcm.com
The potential market cap would be $12,837m based on the market concensus.
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.
